The Signals: What’s Changing and Why It Matters
Following the JPM’26 Healthcare Conference, OneWe Reach convened investors and healthcare strategy leaders to reflect on what they’re seeing and how it will shape action in the year ahead.
Here are a few clear signals that rose to the top:
1. Policy and Regulation
Regulators are increasingly explicit that participation, transparency, and real-world applicability matter. This signals a move away from narrow trial design toward broader accountability for how innovation reaches people.
Why it matters: Leaders who anticipate these expectations will move faster and with greater credibility than those who react late.
2. Capital and Strategy
Investors are scrutinizing not just what companies build, but who benefits. Access, representation, and adoption are now viewed as indicators of long-term value and risk mitigation.
Why it matters: Participation influences valuation, not just ethics.
3. Talent and Leadership
Professionals want to work in environments where innovation aligns with impact. Organizations that connect mission with execution are better positioned to attract and retain leaders who can navigate complexity.
Why it matters: Leadership credibility increasingly depends on alignment between values and outcomes.
Want a deeper read on these signals?
Watch the JPM’26 Decoded conversation for expert insights on capital flows, market shifts, and the forces shaping healthcare strategy in 2026.
